# A Study of Commercial DEFINITY® to Monitor the Effects of the Heart's Pulmonary Artery Pressure

> **NCT00918866** · PHASE4 · COMPLETED · sponsor: **Lantheus Medical Imaging** · enrollment: 32 (actual)

## Conditions studied

- Pulmonary Heart Disease

## Interventions

- **DRUG:** Definity

## Key facts

- **NCT ID:** NCT00918866
- **Lead sponsor:** Lantheus Medical Imaging
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2020-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00918866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00918866, "A Study of Commercial DEFINITY® to Monitor the Effects of the Heart's Pulmonary Artery Pressure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00918866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*